News

Boeing's Cash Challenges: Insights and Outlook for Investors

Boeing's Cash Challenges: Insights and Outlook for Investors

Boeing Faces Financial Headwinds Amid Cash Burn Concerns

Barclays has maintained its Equalweight rating on Boeing (NYSE: BA), setting a price target of $190. The firm has outlined the company's strategy of ongoing cash burn through 2025, a move that may hint at a larger equity raise than previously expected. This perspective arises from Boeing's forecasted $4 billion free cash flow (FCF) burn in the final quarter of the year and anticipated cash outflows between $3-5 billion in 2025, coupled with $12 billion in debt maturities due within that timeframe.

Equity Raise Discussion and Market Reactions

Barclays pointed out Boeing's preparedness for an approximate $20 billion equity raise. Notably, this timing is not dependent on the International Association of Machinists (IAM) vote. Although this forecast indicates a concerning trajectory regarding forecasted free cash flow, resulting in a potentially larger equity offering, the market's minimal reaction suggests investors view this insight as a form of clarity rather than an alarm bell.

Barclays emphasizes that a combination of equity raising efforts alongside an evolving FCF trajectory could serve as a catalyst for a positive shift in Boeing's stock prices. They remain optimistic that IAM's negotiated resolution will pass, anticipating clear outcomes in the near term regardless of the vote results.

Adjustments Following Third-Quarter Results

After reviewing the third-quarter results, Barclays revised their projections to reflect a cash burn expectation for the fourth quarter and into 2025. The new forecast includes reduced deliveries for the MAX and 787 aircraft and an increase in cash outflows within the 777X and Defense segments. According to Barclays, they now forecast $13 billion in free cash flow usage for 2024, followed by $3 billion for 2025. They project a return to positive FCF of $4 billion by 2026 and further increases of $6 billion in 2027 and $8 billion in 2028.

Challenges Surface Amid a $6 Billion Loss

Recently, Boeing has been confronting significant challenges. The company reported a staggering $6 billion loss, primarily due to a strike involving around 33,000 workers, who turned down a labor proposal that excluded a defined benefit pension plan. This protest has lasted for several weeks and has compounded issues already plaguing Boeing's operations, including production stalls on the 737 MAX jets, as well as issues with the 777 and 767 widebody models.

In its quarterly earnings call, Boeing also shared that revenue had dipped slightly to $17.8 billion, accompanied by a core loss per share of $10.44. In light of these challenges, Boeing emphasized its solid backlog and appreciated the commitment of its workforce. The Defense, Space & Security division, which has faced numerous hurdles such as cost overruns and substantial losses, remains a pivotal part of the company's core strategy according to CEO Kelly Ortberg.

Market Insights and Future Projections

Recent data has shed light on Boeing's financial status, corroborating Barclays' analysis. Boeing's market capitalization stands at approximately $97.03 billion, showcasing its substantial footprint within the aerospace sector despite its current adversities. Yet, Boeing’s troubling financial indicators indicate a negative price-to-earnings ratio of -14.48, shedding light on its ongoing struggle for profitability.

Insider tips indicate that Boeing may face difficulties in meeting its debt obligations, which lines up with ongoing cash burn discussions and the threat of imminent debt maturities. It has come to light that 18 analysts have lowered their earnings expectations for Boeing, mirroring Barclays' adjustments and highlighting the decline in projected deliveries.

Concerns Over Profitability

Boeing's gross profit margin, noted at just 5.21% for the last twelve months ending in the third quarter, illustrates the weak position the company currently finds itself in, further solidifying the need for the envisioned equity raise. This enduring financial pressure underscores the potential necessity of a cash infusion for the company.

Frequently Asked Questions

What is Boeing's current stock rating from Barclays?

Barclays has maintained an Equalweight rating on Boeing stock, indicating a balanced view on its performance.

What are the forecasts for Boeing's cash flow in 2025?

Analysts expect Boeing to experience cash burn ranging from $3 to $5 billion in 2025 along with significant maturities due.

How much equity is Boeing preparing to raise?

Boeing is preparing for a potential equity raise of approximately $20 billion, reflecting its response to ongoing financial pressures.

What losses did Boeing report recently?

Boeing reported a major loss of $6 billion, primarily due to ongoing labor strikes affecting its operations.

What challenges is Boeing facing regarding its aircraft deliveries?

There have been reductions in deliveries for the MAX and 787 aircraft, as well as increasing cash burn in other aircraft segments, according to Barclays.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Nonprofit and Partners Gift Homes to Veterans

Updated Category News Views 100

A Heartfelt Gesture on Veterans Day Now this is the kind of story that gets you right in the gut. On November 9, two veterans, who were likely walking into a golf club thinking it was just another evening, were handed the keys to a future they might have only dreamt of: a mortgage-free home. Operation Finally Home, backed by the big names like Lennar and the patriotic...

Continue Reading
Surprising Week on Wall Street: Chips Drive Gains

Updated Category News Views 141

A Wild Week in Wall Street Well, folks, what a week it’s been on Wall Street. The indexes danced the cha-cha, making gains despite closing Friday on a lower note. Despite the retreat, we've got ourselves a week where the major indexes closed higher than the previous Friday. It's not the usual story, but who ever thought stocks played by the rules? The Nasdaq Composite...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 141

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 83

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
LA Fitness ELEVATE Opens at RITHM: A New Era Dawns

Updated Category News Views 66

Elevating Fitness at RITHM: A New Era Has Begun RD Management just dropped a new ace in Tampa Bay’s hand—LA Fitness ELEVATE at the RITHM at Uptown. They lit up the scene with this 30,000-square-foot beast of a gym, and I’ll tell you, it’s not your standard run-of-the-mill joint. When you toss twelve-and-a-half million bucks into a pot, you're aiming to lure folks...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 99

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 155

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Gemmy's Holiday Lights: Bright Ideas for 2026

Updated Category News Views 149

Deep in the heart of Dallas, Gemmy Industries is out to sprinkle a bit of magic over the holiday season for 2026. This ain't your grandma's string lights we're talkin' about here. We're diving headfirst into a new world of seasonal decor with tech-driven lights that look like they came straight outta a winter wonderland. And hey, if Walmart's set to host this lineup, you...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 177

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading

Top 5 Most Recently Viewed Articles

NexPoint Capital Launches Tender Offer for Shareholders

Updated Category News Views 217

NexPoint Capital Begins Tender Offer for Its Common Stock NexPoint Capital, Inc. (the "Company"), a publicly registered business development company expertly managed by NexPoint Advisors, L.P., is set to kick off a voluntary tender offer aimed at going after up to 2.5% of its outstanding common shares. This offer is designed to provide shareholders an opportunity to sell...

Continue Reading
Experience the Winter Wheat Wonderland Pop-Up by Maker's Mark

Updated Category News Views 223

Immerse Yourself in Maker's Mark's Winter Wheat Wonderland Get ready to experience something truly unique this holiday season as Maker's Mark unveils its enchanting pop-up event, the Winter Wheat Wonderland. This special event will take the vibrant spirit of Kentucky bourbon to the heart of New York City, creating a magical atmosphere for all attendees. Details of the...

Continue Reading
Innovative Muscle Composition Study Enhances Liver Transplant Care

Updated Category News Views 202

Assessment of Muscle Composition in Liver Transplant Candidates In a groundbreaking study, the utilization of AMRA Profiler 4, an advanced body-composition analysis device, was analyzed for its effectiveness in evaluating muscle composition among liver transplant candidates suffering from end-stage liver disease (ESLD). This study aims to shed light on critical health...

Continue Reading
Hansa Biopharma's Major Milestones Anticipated in 2025

Updated Category News Views 688

Hansa Biopharma's Participation in Healthcare Conferences Hansa Biopharma AB, a pioneering biopharmaceutical company, is set to make a significant presence at the 2025 J.P. Morgan Healthcare Conference. The company is renowned for its innovative approaches in addressing rare immunological disorders and has been actively engaged in developing novel therapies. This...

Continue Reading
AI for Customer Service: The Next Big Market Leap Ahead

Updated Category News Views 137

AI for Customer Service Market Growth Overview The AI for customer service market is on a remarkable trajectory, set to expand significantly over the next few years. Current projections indicate that the market size will grow from USD 12.06 billion in the near term to an impressive USD 47.82 billion by the end of the decade, achieving a compound annual growth rate (CAGR)...

Continue Reading